ClinicalTrials.govpublic full text
Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 (Erdafitinib) in Participants With Advanced Hepatocellular Carcinoma
carcinoma, hepatocellular, jnj 42756493, a pan-fibroblast growth factor receptor tyrosine kinase inhibitor, interventional, phase1, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗Related documents
Record · ID 892478
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.